Task 5 Public Comments

Transplant Community Feedback

Transplant Provider | 11/17/21

Please stop publishing metrics that rank programs based on statistical differences and not CLINICALLY RELEVANT differences. It hampers innovation and makes programs risk averse. There is no clinically meaningful difference between 97% and 94% 1-year survival (often the difference being 1 or 2 patient outcomes).

James Gleason | 11/15/21

Both as a heart recipient out 28 years and as president of TRIO (Transplant Recipients International Organization) I am very interested in supporting this effort in every way possible. I look forward to the July 2022 conference and plan to attend if invited.

Transplant Provider | 11/1/21

Interested in LOS index.